In the first installment of this 2-part episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the AAO Eyecelerator with guests Julia A. Haller, MD, CEO, and David F. Chang, MD. Welcome to the Eyeluminaries podcast 00:10 Quick recap of episode 34 00:52 Intro of Julia A. Haller, MD, CEO 01:47 Tell us about changes you're seeing in leading a large academic center 02:16 How has residency changed in the last years? 06:23 Why are you involved in the Ophthalmology Foundation? 13:05 Intro of David F. Chang, MD 16:51 What do you think about the future of robotics in cataract surgery? 17:51 How do you continue to involve the patient in their care? 20:15 Dr. Chang discusses premium lenses 22:43 What's going on with EyeSustain and what are you excited about in the future? 27:00 Thank you! 35:30 Julia A. Haller, MD, is ophthalmologist-in-chief and CEO at Wills Eye Hospital. David F. Chang, MD, is a world-renowned cataract surgeon and innovator in the field. He is clinical professor of ophthalmology at the University of California, San Francisco, and is in private practice in Los Altos, Calif. He is also the chair of the EyeSustain advisory board. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm disclosures for Garg, Hubschman, Juhasz, and Lindstrom at the time of publication.
